Administration of rotenone enhanced voluntary alcohol drinking behavior in C57BL/6J mice

被引:5
作者
Yoshimoto, Kanji [1 ]
Ueda, Shuichi [2 ]
Kitamura, Yoshihisa [3 ]
Inden, Masatoshi [3 ]
Hattori, Hiroyuki [4 ]
Ishikawa, Noboru [1 ]
McLean, Stuart [1 ]
Ikegaya, Hiroshi [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Forens Med, Kamigyo Ku, Kyoto 6028566, Japan
[2] Dokkyo Univ, Sch Med, Dept Anat & Neurobiol, Mibu, Tochigi 32102, Japan
[3] Kyoto Pharmaceut Univ, Dept Neurobiol, Yamashina Ku, Kyoto 6078414, Japan
[4] Tsuchiura Kyodo Gen Hosp, Div Gen Hosp, Tsuchiura, Ibaraki 3000053, Japan
关键词
Rotenone; Serotonin; Dopamine; Alcohol drinking; Neural degeneration; NIGROSTRIATAL DOPAMINERGIC SYSTEM; PARKINSONS-DISEASE; RAT; NEURODEGENERATION; DYSFUNCTION; ETHANOL;
D O I
10.1016/j.legalmed.2012.03.005
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Rotenone, a commonly used lipophic pesticide, is a high-affinity mitochondrial complex I inhibitor. The aim of this project is to study the causal relationship between changes of brain monoamine levels and drinking behavior in rotenone-treated mice. In the first experiment, we investigated the effects of acute exposure to rotenone (20 mg/kg, p.o.) on the 8-h time limited-access alcohol drinking behavior and brain monoamine levels in C57BL/6J mice at 0, 2, 8 and 24 h. Dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindoleacetic acid (5HIAA) levels in the nucleus accumbens (ACC), caudate-putamen (C/P) and lateral hypothalamus (LH) of rotenone-treated mice were decreased at 2 and/or 8 h. Rotenone-exposed mice showed a suppression of voluntary alcohol intake at 4 and 8 h, but total daily alcohol intake did not differ significantly between the two groups. The effects of chronic exposure to rotenone (1, 5, 10 and 20 mg/kg, p.o. for 30 days) on the alcohol drinking behavior and monoamine levels of rotenone-exposed mice (10 mg/kg, p.o.) were investigated in the second experiment. The mice treated with rotenone showed increases in alcohol drinking behavior. Levels of DA and 5-HT in the ACC and C/P of chronic rotenone-treated mice were decreased, while the ratios of DOPAC to DA in the ACC and C/P and of 5HIAA to 5-HT in the ACC, C/P and DRN were increased significantly. Tyrosine hydroxylase immunoreactivity of chronic rotenone-treated mice (10 mg/kg, p.o.) slightly were decreased in both the striatum and the substantia nigra. Ethanol and acetaldehyde metabolism was not significantly different between mice treated with rotenone (10 mg/kg, p.o.) and controls. It was suggested that rotenone-treated mice had increased alcohol drinking behavior associated with increases in the DA turnover ratios of ACC and striatum to compensate for the neural degeneration. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:229 / 238
页数:10
相关论文
共 24 条
[1]   Expanding insights of mitochondrial dysfunction in Parkinson's disease [J].
Abou-Sleiman, PM ;
Muqit, MMK ;
Wood, NW .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (03) :207-219
[2]   Experimental models of Parkinson's disease [J].
Beal, MF .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (05) :325-332
[3]   Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson's disease model [J].
Choi, Won-Seok ;
Palmiter, Richard D. ;
Xia, Zhengui .
JOURNAL OF CELL BIOLOGY, 2011, 192 (05) :873-882
[4]   Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat [J].
Choi, Won-Seok ;
Kruse, Shane E. ;
Palmiter, Richard D. ;
Xia, Zhengui .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (39) :15136-15141
[5]  
FUJIMIYA T, 1989, J PHARMACOL EXP THER, V249, P311
[6]   Role of nitric oxide in rotenone-induced nigro-striatal injury [J].
He, Y ;
Imam, SZ ;
Dong, ZJ ;
Jankovic, J ;
Ali, SF ;
Appel, SH ;
Le, WD .
JOURNAL OF NEUROCHEMISTRY, 2003, 86 (06) :1338-1345
[7]   Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone [J].
Inden, Masatoshi ;
Kitamura, Yoshihisa ;
Takeuchi, Hiroki ;
Yanagida, Takashi ;
Takata, Kazuyuki ;
Kobayashi, Yuka ;
Taniguchi, Takashi ;
Yoshimoto, Kanji ;
Kaneko, Masahiko ;
Okuma, Yasunobu ;
Taira, Takahiro ;
Ariga, Hiroyoshi ;
Shimohama, Shun .
JOURNAL OF NEUROCHEMISTRY, 2007, 101 (06) :1491-1504
[8]   Parkinsonian Rotenone Mouse Model: Reevaluation of Long-Term Administration of Rotenone in C57BL/6 Mice [J].
Inden, Masatoshi ;
Kitamura, Yoshihisa ;
Abe, Mari ;
Tamaki, Aya ;
Takata, Kazuyuki ;
Taniguchi, Takashi .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (01) :92-96
[9]   Oxidative stress in Parkinson's disease [J].
Jenner, P .
ANNALS OF NEUROLOGY, 2003, 53 :S26-S36